Proposed legislation removes health insurance rebates.

Steady profit, but rising risks and rich valuation give pause.

Profit beats drive shares higher for Australia’s largest asset manager.

Solid result but valuation is stretched.

Shares sell off after results.

Shares fall after announcement that capital will be replenished for loan impairment provisions.

Earnings growth fails to excite investors worried about AI disruption.

We view the shares are materially overvalued.

Investors were pleased with results but our fair value estimate is unchanged.

When strong fundamentals meet persistent valuation headwinds.